Hydroquinone is considered the gold standard treatment for melasma or hyperpigmentation disorders when used in consultation with physicians and is ubiquitously used in over the counter products by millions of consumers in lower concentrations. The main problem with hydroquinone based products and their derivatives is that there are safety concerns related to their use. A large unmet need exists for the safe and effective cosmetic improvement of hyperpigmentation. Sirona Biochem has developed an innovative new skin lightening compound with superior safety, zero hydroquinone and 8 times the efficacy of deoxyarbutin.
If you like to learn more, join us at INNOCOS summit in Vienna on June 9-10 to hear presentation of Attila Hajdu, the Chief Business Development Officer for Sirona Biochem. You can also contact him at firstname.lastname@example.org